Man Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Man Group's XBI Position: Q3 2026 in Review
Man Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2026, closing a stake of 35,717 shares — an estimated $5.65M sold.
Man Group first reported a position in XBI in Q2 2018 and held it in 7 quarters. The position peaked at $8.99M in Q4 2023. 964 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Man Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2026 after selling out during the quarter.
- Man Group sold 35,717 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $5.65M.
- Man Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and held it in 7 quarters.
- Man Group's State Street SPDR S&P Biotech ETF position peaked at $8.99M in Q4 2023.
- 964 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Man Group's 13F filing for Q3 2026, filed 16 Nov 2026.